HealthCare Global Enterprises Limited (NSE:HCG)
662.70
-3.35 (-0.50%)
Oct 1, 2026, 3:29 PM IST
NSE:HCG Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, NSE:HCG stock has a consensus rating of "Strong Buy" and an average price target of ₹816.00. The average 1-year stock price forecast is 23.13% higher than the current stock price, while the lowest is ₹750.00 (+13.17%) and the highest is ₹920.00 (+38.83%).
Price Target: ₹816.00 (+23.13%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:HCG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 9 | 9 | 9 | 8 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 9 | 9 | 10 | 9 |
Financial Forecast
Revenue This Year
29.00B
from 25.45B
Increased by 13.92%
Revenue Next Year
33.26B
from 29.00B
Increased by 14.70%
EPS This Year
9.11
from 3.59
Increased by 153.70%
EPS Next Year
15.28
from 9.11
Increased by 67.63%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.